WallStreetZenWallStreetZen

NASDAQ: CELL
Phenomex Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CELL

Based on 1 analyst offering 12 month price targets for Phenomex Inc.
Min Forecast
$3.00+456.59%
Avg Forecast
$3.00+456.59%
Max Forecast
$3.00+456.59%

Should I buy or sell CELL stock?

Based on 1 analyst offering ratings for Phenomex Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CELL stock forecasts and price targets.

CELL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Stifel Nicolaus
Top 11%
90
HoldMaintains$3.00+456.59%2023-05-12

1 of 1

Forecast return on equity

Is CELL forecast to generate an efficient return?
Company
20.04%
Industry
29.69%
Market
89.37%
CELL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CELL forecast to generate an efficient return on assets?
Company
10.52%
Industry
11.82%
CELL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CELL revenue growth forecast

How is CELL forecast to perform vs Biotechnology companies and vs the US market?
Company
38.09%
Industry
64.21%
Market
8.83%
CELL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CELL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CELL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CELL$0.54$3.00+456.59%Hold
AVTX$4.02$6.00+49.25%Hold
MBIO$6.55$7.00+6.87%Buy
AVRO$1.22$5.50+350.82%Strong Buy
PASG$0.96$10.00+940.58%Strong Buy
View Top Biotech Stocks

Phenomex Stock Forecast FAQ

Is Phenomex Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CELL) stock is to Hold CELL stock.

Out of 1 analyst, 0 (0%) are recommending CELL as a Strong Buy, 0 (0%) are recommending CELL as a Buy, 1 (100%) are recommending CELL as a Hold, 0 (0%) are recommending CELL as a Sell, and 0 (0%) are recommending CELL as a Strong Sell.

If you're new to stock investing, here's how to buy Phenomex stock.

What is CELL's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: CELL) forecast ROE is 20.04%, which is considered strong.

What is CELL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CELL price target, the average CELL price target is $3.00, with the highest CELL stock price forecast at $3.00 and the lowest CELL stock price forecast at $3.00.

The Wall Street analyst predicted that Phenomex's share price could reach $3.00 by May 12, 2024. The average Phenomex stock price prediction forecasts a potential upside of 456.59% from the current CELL share price of $0.54.

What is CELL's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: CELL) forecast ROA is 10.52%, which is lower than the forecast US Biotechnology industry average of 11.82%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.